Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

50.0%

2 terminated/withdrawn out of 4 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05223751Not ApplicableTerminated

Parasympathetic Augmentation Via Respiratory Training for Patients With Systolic Heart Failure

Role: collaborator

NCT03523247Not ApplicableCompleted

A Whole Food Plant Diet and Its Lipidemic Effects on Primary Prevention in a Free-range Population

Role: collaborator

NCT02381262Not ApplicableCompleted

Fitbit / Healthy Weight Management Study

Role: collaborator

NCT01330589Not ApplicableWithdrawn

Pharmacodynamic Study on Efficacy of Clopidogrel With St. John's Wort

Role: collaborator

All 4 trials loaded